Wolverine Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$39.6K Buy
28,500
+7,400
+35% +$8.4K ﹤0.01% 5461
2025
Q2
$17.3K Sell
21,100
-4,800
-19% -$3.11K ﹤0.01% 4477
2025
Q1
$14.8K Buy
25,900
+8,400
+48% +$5.3K ﹤0.01% 4585
2024
Q4
$12.6K Buy
17,500
+5,600
+47% +$6.75K ﹤0.01% 5142
2024
Q3
$19K Sell
11,900
-7,100
-37% -$12.6K ﹤0.01% 4643
2024
Q2
$31.9K Buy
+19,000
New +$34.1K ﹤0.01% 4282
2024
Q1
Sell
-33,400
Closed -$51.1K 5325
2023
Q4
$51.1K Buy
+33,400
New +$39.7K ﹤0.01% 4254
2023
Q2
Sell
-16,000
Closed -$37K 5104
2023
Q1
$37K Buy
16,000
+4,000
+33% +$9.17K ﹤0.01% 3894
2022
Q4
$23K Buy
+12,000
New +$25.5K ﹤0.01% 3715
2022
Q3
Sell
-28,900
Closed -$65K 5470
2022
Q2
$65K Buy
28,900
+400
+1% +$763 ﹤0.01% 3988
2022
Q1
$60K Sell
28,500
-1,100
-4% -$3.05K ﹤0.01% 5024
2021
Q4
$123K Buy
29,600
+15,300
+107% +$74.3K ﹤0.01% 5002
2021
Q3
$70K Sell
14,300
-12,600
-47% -$51.7K ﹤0.01% 5922
2021
Q2
$135K Sell
26,900
-14,700
-35% -$70.8K ﹤0.01% 5256
2021
Q1
$236K Buy
41,600
+8,800
+27% +$60.9K ﹤0.01% 4814
2020
Q4
$109K Buy
32,800
+16,200
+98% +$30.9K ﹤0.01% 4443
2020
Q3
$24K Buy
16,600
+3,200
+24% +$5.7K ﹤0.01% 4374
2020
Q2
$27K Buy
+13,400
New +$26.3K ﹤0.01% 4407
2020
Q1
Sell
-18,700
Closed -$77K 5245
2019
Q4
$77K Sell
18,700
-1,400
-7% -$5.39K ﹤0.01% 4358
2019
Q3
$69K Sell
20,100
-10,900
-35% -$33.7K ﹤0.01% 3967
2019
Q2
$195K Buy
31,000
+5,600
+22% +$33.5K 0.01% 3732
2019
Q1
$141K Buy
+25,400
New +$154K ﹤0.01% 4014
2018
Q3
Sell
-11,000
Closed -$94K 5765
2018
Q2
$94K Hold
11,000
﹤0.01% 4742
2018
Q1
$94K Sell
11,000
-300
-3% -$2.77K ﹤0.01% 4742
2017
Q4
$112K Sell
11,300
-4,300
-28% -$44.7K ﹤0.01% 4416
2017
Q3
$192K Buy
+15,600
New +$230K 0.01% 3835

Other funds holding LXRX